These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10433373)

  • 61. Intestinal T cell responses to cereal proteins in celiac disease.
    Kilmartin C; Wieser H; Abuzakouk M; Kelly J; Jackson J; Feighery C
    Dig Dis Sci; 2006 Jan; 51(1):202-9. PubMed ID: 16416236
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mucosal digestion studies of whole gliadin fractions in coeliac disease.
    Cornell HJ
    Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():44-9. PubMed ID: 2310157
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The binding of a glycopeptide component of wheat gluten to intestinal mucosa of normal and coeliac human subjects.
    Douglas AP
    Clin Chim Acta; 1976 Dec; 73(2):357-61. PubMed ID: 1000854
    [TBL] [Abstract][Full Text] [Related]  

  • 64. No induction of anti-avenin IgA by oats in adult, diet-treated coeliac disease.
    Guttormsen V; Løvik A; Bye A; Bratlie J; Mørkrid L; Lundin KE
    Scand J Gastroenterol; 2008; 43(2):161-5. PubMed ID: 18224563
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The opioid effects of gluten exorphins: asymptomatic celiac disease.
    Pruimboom L; de Punder K
    J Health Popul Nutr; 2015 Nov; 33():24. PubMed ID: 26825414
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Agglutinating activity of wheat gliadin peptide fractions in coeliac disease.
    De Vincenzi M; Dessi MR; Giovannini C; Maialetti F; Mancini E
    Toxicology; 1995 Jan; 96(1):29-35. PubMed ID: 7863509
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enzyme-linked immunosorbent assay for quantitation of cereal proteins toxic in coeliac disease.
    Friis SU
    Clin Chim Acta; 1988 Dec; 178(3):261-70. PubMed ID: 3240601
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Agglutinating activity of alcohol-soluble proteins from quinoa seed flour in celiac disease.
    De Vincenzi M; Silano M; Luchetti R; Carratù B; Boniglia C; Pogna NE
    Plant Foods Hum Nutr; 1999; 54(2):93-100. PubMed ID: 10646556
    [TBL] [Abstract][Full Text] [Related]  

  • 69. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue.
    De Angelis M; Rizzello CG; Fasano A; Clemente MG; De Simone C; Silano M; De Vincenzi M; Losito I; Gobbetti M
    Biochim Biophys Acta; 2006 Jan; 1762(1):80-93. PubMed ID: 16311022
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Deficient activity of mammalian prolyl oligopeptidase on the immunoactive peptide digestion in coeliac disease.
    Garcia-Horsman JA; Venäläinen JI; Lohi O; Auriola IS; Korponay-Szabo IR; Kaukinen K; Mäki M; Männistö PT
    Scand J Gastroenterol; 2007 May; 42(5):562-71. PubMed ID: 17454876
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of the safety of ancient strains of wheat in coeliac disease reveals heterogeneous small intestinal T cell responses suggestive of coeliac toxicity.
    Šuligoj T; Gregorini A; Colomba M; Ellis HJ; Ciclitira PJ
    Clin Nutr; 2013 Dec; 32(6):1043-9. PubMed ID: 23465776
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Digestion of gliadin peptides by intestinal mucosa from control or coeliac children.
    Carchon H; Serrus M; Eggermont E
    Digestion; 1979; 19(1):1-5. PubMed ID: 378739
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A curated gluten protein sequence database to support development of proteomics methods for determination of gluten in gluten-free foods.
    Bromilow S; Gethings LA; Buckley M; Bromley M; Shewry PR; Langridge JI; Clare Mills EN
    J Proteomics; 2017 Jun; 163():67-75. PubMed ID: 28385663
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vitro hydrolysis of gliadin and casein peptides: secondary defect in coeliac disease shown by organ culture.
    Walz F; Wieser H; Stern M
    Scand J Gastroenterol; 1996 Mar; 31(3):240-6. PubMed ID: 8833353
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of coeliac disease triggering glutenin peptides in adults.
    Donnelly SC; Šuligoj T; Ellis HJ; Ciclitira PJ
    Scand J Gastroenterol; 2016 Jul; 51(7):819-26. PubMed ID: 26911209
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa.
    Fais S; Maiuri L; Pallone F; De Vincenzi M; De Ritis G; Troncone R; Auricchio S
    Gut; 1992 Apr; 33(4):472-5. PubMed ID: 1582589
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lysosomal damage by gliadin and gliadin peptides; an activity not related to coeliac disease.
    de Rooij FW; van den Aarsen CP; Hekkens WT
    Clin Chim Acta; 1979 Jan; 91(2):127-31. PubMed ID: 759040
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The determination of prolamins in gluten-free food. Introductory remarks.
    Hekkens WT
    Panminerva Med; 1991; 33(2):61-4. PubMed ID: 1923556
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Alpha gliadin antibody levels: a serological test for coeliac disease.
    O'Farrelly C; Kelly J; Hekkens W; Bradley B; Thompson A; Feighery C; Weir DG
    Br Med J (Clin Res Ed); 1983 Jun; 286(6383):2007-10. PubMed ID: 6409205
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gluten-free diet--what is toxic?
    Ciclitira PJ; Ellis HJ; Lundin KE
    Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):359-71. PubMed ID: 15925842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.